期刊名称：THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
eISSN: 20420196 | ISSN: 20420188
Journal highlights
- Launched in 2010
- Impact Factor: 3.978
- Indexed in PubMed, PubMed Central, Scopus, Science Citation Index Expanded (SCIE) and the Web of Science
- Rigorous peer review
- Rapid publication
- Over 350,000 article views on PubMed Central in 2017
Therapeutic Advances in Endocrinology and Metabolism (TAEM) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of endocrinology and metabolism. Please see the Aims and Scope tab for further information.
Submission information
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence. The APC for this journal is currently $2,000 USD. The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Contact
Please direct any queries to Hemali.Bedi@sagepub.co.uk.This journal changed its publication mode from subscription to open access in 2019.
ABSTRACTING / INDEXING
Emerging Sources Citation Index (ESCI)
PubMed
PubMed Central (PMC)
Scopus
Instructions to Authors
Manuscript Submission Guidelines: Therapeutic Advances in Endocrinology and Metabolism
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/tae to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Therapeutic Advances in Endocrinology and Metabolism will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Therapeutic Advances in Endocrinology and Metabolism may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.
If your paper is accepted, you must include a link on your preprint to the final version of your paper.
- Open Access
- Article processing charge
- What do we publish?
4.1 Aims & Scope
4.2 Article types
4.3 Writing your paper
- Editorial policies
4.1 Peer review policy
4.2 Authorship
4.3 Acknowledgements
4.4 Funding
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.2 Contributor's publishing agreement
5.3 Open access and author archiving
- Preparing your manuscript
6.1 Formatting
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 ORCID
7.2 Information required for completing your submission
7.3 Permissions
- On acceptance and publication
8.1 SAGE Production
8.2 Online publication
8.3 Promoting your article
- Further information
Editorial Board
| Lee Kennedy |
James Cook University, Townsville, Australia |
| Stephen Atkin |
Weill Cornell Medicine - Qatar, Al-Rayyan, Qatar |
| Clifford J Bailey |
Aston University, Birmingham, UK |
| Pierre-Marc Bouloux |
Royal Free Hospital, London, UK |
| Ketan Dhatariya |
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norfolk, UK |
| Neil Gittoes |
Queen Elizabeth Hospital, Birmingham, UK |
| Cheng Han |
Albert Einstein College of Medicine, New York, NY, USA |
| Robin Lachmann |
National Hospital for Neurology and Neurosurgery, London, UK |
| Rayaz Malik |
University of Manchester, Manchester, UK |
| Eugene McCloskey |
University of Sheffield, Sheffield, UK |
| Luigi Meneghini |
University of Texas Southwestern Medical Center, Dallas, TX, USA |
| Francesco Paneni |
University of Zürich, Zürich, Switzerland |
| Gregory Pastores |
University College Dublin, Dublin, Ireland |
| Richard Quinton |
Royal Victoria Infirmary, Newcastle-upon-Tyne, UK |
| Peter Selby |
University of Manchester, Manchester, UK |
|
